Alignment Healthcare Exceeds Q2 Guidance, Raises Full-Year Outlook on Strong Growth
ALHC sits 55% above its 52-week low of $12.01.
Summary
Alignment Healthcare reported strong second-quarter 2026 financial results, exceeding its own guidance across all key metrics, driven by robust revenue and membership growth. The company also raised its full-year guidance, indicating a positive outlook.
Updates
· SEC 10-Q — The 10-Q reports Q2 net income of $36.6 million, up from $15.7 million a year earlier, and six-month net income of $48.0 million.
· Dow Jones Newswires — Q2 EPS was 17 cents, a figure not included in the earlier 8-K.
Key Events · Earnings and Guidance · ALHC
-
Strong Q2 2026 Financial Performance
The company exceeded the high end of its guidance, reporting $1,335.6 million in total revenue (up 31.6% year-over-year), $182.9 million in adjusted gross profit (up 35.3% year-over-year), and $68.1 million in adjusted EBITDA (up 48.4% year-over-year). Net income more than doubled to $36.6 million.
-
Significant Membership Growth
Medicare Advantage membership grew 31.5% year-over-year, reaching approximately 294,100 members by the end of the second quarter.
-
Raised Full-Year Guidance
Alignment Healthcare increased the midpoint of all its full-year guidance metrics, including membership, revenue, adjusted gross profit, and adjusted EBITDA, signaling continued confidence in its operational performance.
Analysis · ALHC · Finance
This 8-K announces Alignment Healthcare's Q2 2026 earnings, which significantly surpassed the high end of the company's own guidance. Key metrics like revenue, adjusted gross profit, and adjusted EBITDA showed substantial year-over-year growth, with net income more than doubling. The company's decision to raise the midpoint of all full-year guidance metrics, including membership and revenue, suggests strong operational momentum and improved future profitability expectations. This positive financial update is likely to be well-received by investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALHC was trading at $18.61 on NASDAQ in the Finance sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $12.01 to $25.12. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.